Search

everythinglearnresearchcommunity

for

Search:↓

Multi-pass laser skin treatments improved healing, reduced pain, and had no major complications.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

Some vitamins, amino acids, and alternative medicines can cause serious side effects, including bone, muscle, and skin issues, and healthcare professionals should be aware of these risks.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Freeze-dried dexamethasone nanoparticles in a hydrogel are stable and effective for treating alopecia areata.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

Stem-cell therapy shows promise for skin conditions but needs more research.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Baricitinib may effectively treat nail changes in alopecia areata.

Hair removal with intense pulsed light can cause rare skin lesions that are hard to fully treat.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

A witch-hazel-based 5% minoxidil solution is effective and safe for women with hair loss who didn't respond to regular minoxidil, especially if they're sensitive to propylene glycol.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Acupuncture and moxibustion may help treat hair loss, but more research is needed.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Cyclosporine is effective for skin conditions but has declined in use due to toxicity concerns.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.